Axis-Shield & Abbott Laboratories in drug test deal
This article was originally published in Clinica
Executive Summary
Abbott Laboratories will market and distribute an athletes' drug test to be developed and manufactured by Anglo-Norwegian company Axis-Shield under an agreement reached between the two companies last month. The test will screen athletes for levels of testosterone, abnormally high levels of which can indicate that an athlete is taking banned performance enhancing drugs. It will be used on Abbott's AxSym automated immunoassay testing platform, which combines continuous and random access and STAT capabilities.
You may also be interested in...
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.